After Nine Years, Spectrum Pharmaceuticals CEO To Retire

Spectrum Pharmaceuticals Inc SPPI has named Tom Riga the next President and CEO effective December 31, 2021. He currently serves as the Chief Commercial and Chief Operating Officer of Spectrum.

• After nine years with the company, Joseph Turgeon, President, and CEO has agreed to retire from Spectrum on December 31, 2021. 
• Accordingly, he will also be stepping down from Spectrum's Board of Directors.
• Mr. Riga joined the company in July 2013 as VP of Corporate Accounts and was named Chief Commercial Officer in August 2014 and Chief Operating Officer in December 2017. 
• Mr. Riga has over 20 years of pharmaceutical experience.
• Also See: Spectrum Pharma Stock Craters As FDA Slaps Response Letter For Its Neutropenia Candidate.
• Price Action: SPPI shares are trading 0.60% lower at $1.67 premarket on the last check Thursday.